Nadia Luheshi
AstraZeneca (United Kingdom)(GB)Horizon Discovery (United Kingdom)(GB)AstraZeneca (Brazil)(BR)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune cells in cancer, Immune Cell Function and Interaction
Most-Cited Works
- → Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment(2020)209 cited
- → Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies(2019)201 cited
- → Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome(2012)164 cited
- → Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues(2011)137 cited
- → Zinc depletion regulates the processing and secretion of IL-1β(2014)103 cited
- → Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model(2016)